Jissy Thomas
Nurse Practitioner · North Las Vegas, NVNPI 1184156838
Payments from drug & device makers
Across 10 payments — averaging $45.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SK Life Science, Inc.$152
- Neurocrine Biosciences, Inc.$152
- Tactile Systems Technology Inc$85
- Otsuka America Pharmaceutical, Inc.$31
- Alkermes, Inc.$22
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$16
What the payments were for
- Food & beverage$459100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SK Life Science, Inc. | 4 | $152 |
| Neurocrine Biosciences, Inc. | 1 | $152 |
| Tactile Systems Technology Inc | 1 | $85 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Alkermes, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
How this compares
$459 in reported general payments places this provider in the 60th percentile of 933 nurse practitioner providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 151 | $49,756 |
| OzempicSemaglutide | 16 | $16,283 |
| JardianceEmpagliflozin | 34 | $11,123 |
| XareltoRivaroxaban | 22 | $7,246 |
| Potassium Chloride | 142 | $3,105 |
| Atorvastatin Calcium | 294 | $3,007 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 50 | $2,672 |
| Gabapentin | 106 | $1,774 |
| Humalog Kwikpen U-100Insulin Lispro | 16 | $1,745 |
| LokelmaSodium Zirconium Cyclosilicate | 13 | $1,709 |
| Rosuvastatin Calcium | 36 | $1,320 |
| Midodrine Hcl | 28 | $1,283 |
| Megestrol Acetate | 14 | $1,046 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 13 | $1,038 |
| Losartan Potassium | 76 | $905 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in North Las Vegas
- Charina TosteHenderson$393K
- Vanessa AntolinLas Vegas$225K
- Shannon SouthwickLas Vegas$85K
- Melanie SpeedLas Vegas$80K
- Shelley MilesLas Vegas$34K
- Nasslynne LenzLas Vegas$32K
- Bonnie KwanLas Vegas$30K
- Amanda RalphLas Vegas$26K
- Teodoro AgtayLas Vegas$25K
- Melissa DelamoraReno$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.